Revolution Medicines Overview
Revolution Medicines Target Price
Where could RVMD trade next? Consensus target price: $220.
Get informed when a big investor buys or sells
+ FollowShare Price
$210.02
Average Target Price
$222.69
6% upside
6% upside29 analysts in the last 4 months
High: $320 | Low: $151
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-31 | Needham | $275 | 30.9% upside |  |
| 2026-08-28 | UBS | $265 | 26.2% upside | |
| 2026-08-28 | Guggenheim | $275 | 30.9% upside | |
| 2026-08-27 | RBC CapitalLeonid Timashev | $251 | 19.5% upside | |
| 2026-08-27 | Raymond JamesSean McCutcheon | $248 | 18.1% upside | |
| 2026-08-27 | Evercore ISI | $320 | 52.4% upside | |
| 2026-08-27 | H.C. WainwrightRobert Burns | $280 | 33.3% upside | |
| 2026-08-26 | Oppenheimer | $260 | 23.8% upside | |
| 2026-08-21 | BernsteinJeffrey Walch | $179 |  14.8% downside | |
| 2026-08-11 | Truist Financial | $231 | 10% upside | |
| 2026-08-10 | Wolfe ResearchKalpit Patel | $220 | 4.8% upside | |
| 2026-08-06 | Evercore ISI | $230 | 9.5% upside | |
| 2026-08-06 | Wedbush | $201 | 4.3% downside | |
| 2026-08-06 | Oppenheimer | $230 | 9.5% upside | |
| 2026-08-06 | RBC Capital | $203 | 3.3% downside | |
| 2026-08-06 | GuggenheimMichael Schmidt | $240 | 14.3% upside | |
| 2026-07-23 | WedbushRobert Driscoll | $192.1 | 8.5% downside | |
| 2026-07-09 | GuggenheimMichael Schmidt | $235 | 11.9% upside | |
| 2026-07-06 | Mizuho Securities | $215 | 2.4% upside | |
| 2026-07-02 | Wedbush | $181 | 13.8% downside | |
| 2026-06-30 | Truist Financial | $210 | 0% upside | |
| 2026-06-29 | NeedhamAmi Fadia | $235 | 11.9% upside | |
| 2026-06-09 | UBSMichael Yee | $175 | 16.7% downside | |
| 2026-06-02 | RBC CapitalLeonid Timashev | $182 | 13.3% downside | |
| 2026-06-01 | H.C. Wainwright | $195 | 7.2% downside | |
| 2026-06-01 | Oppenheimer | $195 | 7.2% downside | |
| 2026-05-21 | BernsteinJeffrey Walch | $151 | 28.1% downside | |
| 2026-05-18 | Truist Financial | $179 | 14.8% downside | |
| 2026-05-07 | Guggenheim | $205 | 2.4% downside | |
| 2026-04-14 | Guggenheim | $175 | 16.7% downside | |
| 2026-04-14 | Evercore ISI | $200 | 4.8% downside | |
| 2026-04-14 | RBC Capital | $162 | 22.9% downside | |
| 2026-04-14 | H.C. WainwrightRobert Burns | $169 | 19.5% downside | |
| 2026-04-13 | Oppenheimer | $165 | 21.4% downside | |
| 2026-02-26 | Wells FargoEva Fortea Verdejo | $144 | 31.4% downside | |
| 2026-01-27 | OppenheimerJay Olson | $150 | 28.6% downside | |
| 2026-01-22 | UBS | $170 | 19.1% downside | |
| 2026-01-21 | RBC CapitalLeonid Timashev | $140 | 33.3% downside | |
| 2026-01-20 | Guggenheim | $160 | 23.8% downside | |
| 2026-01-13 | Goldman SachsAndrea Newkirk | $73 | 65.2% downside | |
| 2026-01-13 | Mizuho Securities | $143 | 31.9% downside | |
| 2026-01-09 | Wedbush | $147 | 30% downside | |
| 2025-11-03 | RBC CapitalLeonid Timashev | $77 | 63.3% downside | |
| 2025-10-17 | National BankAlex Stranahan | $80 | 61.9% downside | |
| 2025-10-17 | Raymond James | $76 | 63.8% downside | |
| 2025-10-15 | Stifel Nicolaus | $85 | 59.5% downside | |
| 2025-09-05 | Truist Financial | $99 | 52.9% downside | |
| 2025-08-19 | Piper SandlerKelsey Goodwin | $75 | 64.3% downside | |
| 2025-05-14 | H.C. WainwrightRobert Burns | $72 | 65.7% downside | |
| 2025-04-01 | Stifel NicolausBenjamin Burnett | $64 | 69.5% downside | |